National Cancer Institute (NCI) shared a post on LinkedIn:
“The National Cancer Institute mourns the passing of Joseph F. Fraumeni, Jr., M.D., one of the world’s most influential cancer epidemiologists and a visionary leader at NCI.
As the founder of NCI’s Division of Cancer Epidemiology and Genetics, Dr. Fraumeni transformed our understanding of the genetic and environmental causes of cancer, pioneered the field of molecular epidemiology, and inspired generations of scientists.
Among his many scientific achievements, Dr. Fraumeni and his colleague Dr. Frederick Li described the inherited cancer predisposition condition now known as Li-Fraumeni syndrome, a discovery that continues to guide research and patient care worldwide.
We extend our condolences to his family, friends, colleagues, and all those whose lives and careers he touched.”
To which Wei Zhang, Director, Center for Cancer Systems Informatics/Fellow at National Foundation for Cancer Research, added:
“In my early years as a cancer researcher, there was not a single week that went by without talking about Li-Fraumeni Syndrome.
‘Combining his insights as a skilled clinician with the rigor of epidemiologic investigation, he pioneered studies of cancer-prone families. Along with his colleague, the late Frederick P. Li, M.D., he identified a familial cancer predisposition syndrome associated with rare inherited variants in the TP53 tumor suppressor gene.’
Remembering Joseph F. Fraumeni, Jr.”
Other articles about NCI on OncoDaily.